EN
HI

ALIVUS LIFE SCIENCES Share price

ALIVUS

HealthcareLarge

1111

23.10 (2.12%)
NSE
BSE
Last updated on 6 May, 2025 | 15:31 IST
BUYSELL
Today's High

1070.20

Today's Low

1125.00

52 Week Low

1335.10

52 Week High

1335.10

The current prices are delayed, login to your account for live prices

Alivus Life Sciences Chart

ALIVUS LIFE SCIENCES Share Key Metrics

Volume
1.37 L
Market Cap
13613.87 CR
LTQ@LTP
11@1111.00
ATP
1103.92
Var Margin
2105
Circuit Range
870.4-1305.4
Delivery %
45.29
Value
15.09 CR
ASM/GSM
No
Market Lot
1

ALIVUS LIFE SCIENCES Futures & Options

Data Not Found

ALIVUS LIFE SCIENCES Corporate Actions

DateAgenda
2025-01-23Quarterly Results
DateEvent TypeAgenda
2025-01-23Board MeetingQuarterly Results

ALIVUS LIFE SCIENCES News

Under a new owner, Glenmark Life Sciences aims to shed past constraints

Oct 11 2024 08:26:53
Read More

About ALIVUS LIFE SCIENCES

NSE : 5265  
BSE : 543322  
ISIN : INE03Q201024  

The Company was incorporated as ‘Zorg Laboratories Private Limited’ a private limited company under the Companies Act 1956 on June 23 2011 at Pune and was granted the certificate of incorporation by the RoC. the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4 2018. For further details please see – “Details regarding material acquisitions or divestments of business/ undertakings mergers amalgamations or any revaluation of assets in the last 10 years - Acquisition by Glenmark Pharmaceuticals Limited” on page 151. Pursuant to the acquisition the name of the Company was changed to ‘Glenmark Life Sciences Private Limited’ by way of a special resolution passed by the shareholders of the Company on July 25 2018 and a fresh certificate of incorporation dated August 10 2018 was issued by the RoC. A shareholders’ resolution was passed on August 13 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28 2018 was issued by the RoC. Thereafter the business of active pharmaceutical ingredients was acquired by the Company from the Promoter pursuant to the Business Purchase Agreement.Major events and milestones of the Company :2021- Achieved milestone of 403 cumulative drug master files (DMF) registrations across multiple markets globally2019- The API business was spun off into the Company- Ankleshwar plant inspected by US-FDA Health Canada and PMDA Japan2018- Dahej plant inspected by EDQM ANSM and US-FDA- Mohol plant inspected by US-FDA2016- Dahej plant inspected by PMDA Japan2015- Dahej plant inspected by US-FDA2013- Commenced manufacturing at Dahej Gujarat- Ankleshwar plant inspected by COFEPRIS2012- Ankleshwar plant inspected by PMDA and AFSSAPS2008- Ankleshwar plant at Gujarat inspected by US-FDA2004- Commenced manufacturing at Mohol Maharashtra2003- First product registered with US-FDA- Acquired GlaxoSmithKline’s (GSK) API manufacturing plant in Ankleshwar Gujarat2001 - 2002- The Promoter established its API business- Established manufacturing plant at Kurkumbh MaharashtraAwards accreditations and recognitions received by the Company :2021- Ankleshwar plant received ISO 45001:2018 certifying the management system of the manufacturing facility- Ankleshwar plant received ISO 14001:2015 re-certifying the management system of the manufacturing facility2020- Dahej plant received ISO 45001:2018 certifying the management system of the manufacturing facility- Dahej plant was declared the winner of the Greentech Environment Award for the year 2020 for outstanding achievements in environment protection2019- Ankleshwar plant was awarded Greentech Safety Award as the winner in the pharmaceutical sector by the Greentech Foundation for outstanding achievements in safety management- Dahej plant was awarded Greentech Safety Award for the year 2019 as the runner-up in the pharmaceutical sector by the Greentech Foundation for outstanding achievements in safety management- Dahej plant was declared the winner of the Greentech Environment Award for the year 2019 for outstanding achievements in environment management in the pharmaceutical sector2018- Ankleshwar plant received ISO 14001:2015 re-certifying the management system of manufacturing facility- Dahej plant received ISO 14001:2015 re-certifying the management system of manufacturing facility- Ankleshwar plant was awarded Greentech Safety gold award by the Greentech Foundation for outstanding achievements in safety management2017- Ankleshwar plant was awarded Greentech Safety silver award by the Greentech Foundation for outstanding achievements in safety management2016- Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility- Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility2015- Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility

ALIVUS LIFE SCIENCES Management

NamePosition
Mr. Hiren K Patel Chairman & Non-Exe.Director
Dr. Yasir Rawjee Managing Director & CEO
Mr. Vinod Naik Executive Director
Mrs. Manju Agarwal Independent Director
Mr. Taruvai Laxminarayanan Easwar Independent Director
Read More

ALIVUS LIFE SCIENCES FAQs

The Buying Price of ALIVUS LIFE SCIENCES share is 378.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy ALIVUS LIFE SCIENCES share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of ALIVUS LIFE SCIENCES shares is 30.18. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio ALIVUS LIFE SCIENCES shares is 4.98. Useful to assess the stock's value relative to its book value.

To assess ALIVUS LIFE SCIENCES’s valuation compare Sector P/E, P/B which are 34.16 & 4.86 with sector averages, along with growth rates and financial metrics.

The Market Cap of ALIVUS LIFE SCIENCES is 13613.87 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of ALIVUS LIFE SCIENCES share price is 1335.10 & 755.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.